BRIDGEBIO PHARMA INC

BBIONASDAQ

🏆 #663 by market capEarnings Oct 29 · PostUS Equity

$70.82—

Last available close · quote unavailable

Get earnings, price moves & breaking news on Telegram

24h—

7d▲ 4.0%

14d▲ 5.5%

30d▲ 7.4%

ytd▼ 7.4%

1y▲ 6.3%

🏦Market Cap

$13.84B

Mid Cap

📈Revenue Growth (YoY)

202.4%

High Growth

📊Gross Margin

94.4%

High

💵FCF Margin

—

⚖️P/S Ratio

19.5x

Expensive

Otter Score

68

Fair

Earnings

Q2 · 2026Reported 2026-06-30

Earnings Per Share

Actual

-0.78

Expected

-0.60

miss

−31.10%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

-0.78

miss

Q1 2026

-0.84

miss

Q4 2025

-1.00

miss

Q3 2025

-0.95

miss